FDAnews Drug Daily Bulletin

Novartis to Add Warnings to Rasilez Blood-Pressure Drug

A A
Novartis AG said it will add a warning to the label for its blood-pressure drug Rasilez in Europe to comply with a request from regulators.
Bloomberg